USSF’s COVID-19 Oral and Injectable Vaccines Yield Positive Pre-Clinical Results

Two promising new COVID-19 vaccines show positive results in pre-clinical trials, developed through an alliance formed by Ben Franklin clients VaxForm LLC, a vaccine development company, and US Specialty Formulations LLC (USSF), a cGMP pharmaceutical manufacturing company. These new vaccines utilize novel delivery platforms for COVID-19 with one oral delivery and the other a conventional injectable. Both vaccine formulations produced antibodies in 100% of mice in pre-clinical trials. The company alliance was formed in the Ben Franklin TechVentures business/technology incubator, at which both companies are headquartered. Coverage via Lehigh Valley Business